Funding for this research was provided by:
National Institute of Health (5T32DK007202, K23 DK125266, R03 DK135513)
Article History
Received: 21 May 2023
Accepted: 26 June 2023
First Online: 6 July 2023
Declarations
:
: RY has served as a consultant for Medtronic, Ironwood Pharmaceuticals, Phathom Pharmaceuticals, StatLink MD and Medscape. RY has received research support from Ironwood Pharmaceuticals. RY has served on advisory boards for RJS Mediagnostix with stocks.